Sun Pharma shares drop over 3% on disappointing earnings in Jul-Sep quarter

New Delhi: Shares of Sun Pharmaceutical Industries on Wednesday fell by over 3 percent after the company reported a 59.19 percent decline in consolidated net profit for the September quarter.

Representational image. Getty

Representational image. Getty

The stock slipped 3.29 percent to Rs 508.80 on the BSE.

At the NSE, it fell 3.32 percent to Rs 508.55.

Pharma major Sun Pharmaceutical Industries on Tuesday reported a 59.19 percent drop in consolidated net profit to Rs 912.12 crore for the September quarter, mainly on account of degrowth in the US sales.

The company had posted a net profit of Rs 2,235.14 crore for the corresponding period of the previous fiscal, Sun Pharma said in a BSE filing.

Consolidated total revenue from operations stood at Rs 6,650.34 crore. It was Rs 8,260.11 crore in the same period of the previous year.

Updated Date: Nov 15, 2017 13:52 PM

Also Watch

It's A Wrap: Omerta star Rajkummar Rao in conversation with Parul Sharma
  • Thursday, April 26, 2018 In the Kanjarbhat community, a campaign against 'virginity tests' is slowly gaining ground
  • Thursday, April 19, 2018 Watch: National-level skater and coach Dhwanit Rele trains and nurtures budding athletes
  • Monday, May 14, 2018 FOMO Episode 1: Google Assistant, This is America, Sonam's wedding & Global Warming
  • Saturday, May 19, 2018 Social Media Star: Rajkummar Rao and Bhuvan Bam open up about selfie culture, online trolls

Also See